Skip to main content
. 2018 Sep 4;13(9):e0202650. doi: 10.1371/journal.pone.0202650

Fig 2. Cumulative incidence of overall survival with respect to various clinicopathological factors.

Fig 2

Patients with HCV-related HCC (A), the absence of liver cirrhosis (B), antiviral therapy for hepatitis viral infection (C), the absence of recurrent HCC (D), and late recurrence (E) had significantly higher overall survival rates than their counterparts.